Schedule 13G ownership disclosure

AMRYT PHARMA LTD - SPNR ADR

Security class unavailable · CUSIP: 03217L106

Event date: 2020-12-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
110,503,502
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-20-000707
Form type
SC 13G
Filer
Amryt Pharma plc
CIK
CIK 1783010
Filed
Dec 22, 2020
Reporting period
Dec 10, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub